| Exposing and addressing tobacco industry conduct in low-income and middle-income countries AB Gilmore, G Fooks, J Drope, SA Bialous, RR Jackson The Lancet 385 (9972), 1029-1043, 2015 | 386 | 2015 |
| The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR G Fooks, A Gilmore, J Collin, C Holden, K Lee Journal of business ethics 112, 283-299, 2013 | 364 | 2013 |
| Globalization and infectious diseases: a review of the linkages L Saker, K Lee, B Cannito, A Gilmore, DH Campbell-Lendrum World Health Organization, 2004 | 320 | 2004 |
| How does the alcohol industry attempt to influence marketing regulations? A systematic review E Savell, G Fooks, AB Gilmore Addiction 111 (1), 18-32, 2016 | 281 | 2016 |
| How does the tobacco industry attempt to influence marketing regulations? A systematic review E Savell, AB Gilmore, G Fooks PloS one 9 (2), e87389, 2014 | 273 | 2014 |
| Determinants of and inequalities in self-perceived health in Ukraine ABC Gilmore, M McKee, R Rose Social science & medicine 55 (12), 2177-2188, 2002 | 242 | 2002 |
| Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study A Gilmore, J Pomerleau, M McKee, R Rose, CW Haerpfer, D Rotman, ... American journal of public health 94 (12), 2177-2187, 2004 | 241 | 2004 |
| Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction M Sims, R Maxwell, L Bauld, A Gilmore Bmj 340, 2010 | 233 | 2010 |
| The policy dystopia model: an interpretive analysis of tobacco industry political activity S Ulucanlar, GJ Fooks, AB Gilmore PLoS medicine 13 (9), e1002125, 2016 | 231 | 2016 |
| Defining and conceptualising the commercial determinants of health AB Gilmore, A Fabbri, F Baum, A Bertscher, K Bondy, HJ Chang, ... The Lancet 401 (10383), 1194-1213, 2023 | 223 | 2023 |
| What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies KE Smith, E Savell, AB Gilmore Tobacco control 22 (2), e1-e1, 2013 | 206 | 2013 |
| Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease? AB Gilmore, E Savell, J Collin Journal of Public Health 33 (1), 2-4, 2011 | 201 | 2011 |
| Tobacco industry influence on science and scientists in Germany T Grüning, AB Gilmore, M McKee American Journal of Public Health 96 (1), 20-32, 2006 | 194 | 2006 |
| Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents GJ Fooks, AB Gilmore, KE Smith, J Collin, C Holden, K Lee PLoS medicine 8 (8), e1001076, 2011 | 190 | 2011 |
| Trends in the prevalence of smoking in Russia during the transition to a market economy F Perlman, M Bobak, A Gilmore, M McKee Tobacco control 16 (5), 299-305, 2007 | 175 | 2007 |
| Understanding tobacco industry pricing strategy and whether it undermines tobacco tax policy: the example of the UK cigarette market AB Gilmore, B Tavakoly, G Taylor, H Reed Addiction 108 (7), 1317-1326, 2013 | 171 | 2013 |
| E-cigarettes and equity: a systematic review of differences in awareness and use between sociodemographic groups G Hartwell, S Thomas, M Egan, A Gilmore, M Petticrew Tobacco control 26 (e2), e85-e91, 2017 | 141 | 2017 |
| Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union—part I: establishing cigarette imports AB Gilmore, M McKee Tobacco control 13 (2), 143-150, 2004 | 131 | 2004 |
| Changes in smoking prevalence in Russia, 1996–2004 M Bobak, A Gilmore, M McKee, R Rose, M Marmot Tobacco control 15 (2), 131-135, 2006 | 129 | 2006 |
| “Working the system”—British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents KE Smith, G Fooks, J Collin, H Weishaar, S Mandal, AB Gilmore PLoS Medicine 7 (1), e1000202, 2010 | 128 | 2010 |
